Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RECTIV | AbbVie | N-021359 RX | 2011-06-21 | 1 products, RLD, RS |
NITROGLYCERIN IN DEXTROSE 5% | Baxter | N-019970 RX | 1989-12-29 | 3 products, RLD, RS |
NITROMIST | Evus Health Solutions | N-021780 RX | 2006-11-02 | 1 products, RLD, RS |
NITROLINGUAL PUMPSPRAY | Pohl-Boskamp | N-018705 RX | 1997-01-10 | 1 products, RLD, RS |
NITRO-DUR | USpharma | N-020145 RX | 1995-04-04 | 6 products, RLD, RS |
NITROSTAT | Viatris | N-021134 RX | 2000-05-01 | 3 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
basic dental emergency kit | unapproved drug other | 2024-10-03 |
deluxe dental emergency kit | unapproved drug other | 2024-10-03 |
gonitro | New Drug Application | 2018-06-20 |
minitran | Export only | 2025-01-15 |
nitro-bid | ANDA | 2024-09-04 |
nitro-dur | New Drug Application | 2023-05-30 |
nitro-time | unapproved drug other | 2018-10-09 |
nitroglycerin | ANDA | 2025-09-02 |
nitroglycerin in dextrose | New Drug Application | 2022-12-09 |
nitroglycerin in dextrose | New Drug Application | 2016-08-22 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 377 | 791 | 195 | 14 | 54 | 1249 |
Leukemia | D007938 | — | C95 | 285 | 504 | 136 | 18 | 43 | 859 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 110 | 361 | 176 | 13 | 44 | 638 |
Multiple myeloma | D009101 | — | C90.0 | 200 | 360 | 65 | 8 | 24 | 567 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 183 | 315 | 68 | 3 | 21 | 499 |
Plasma cell neoplasms | D054219 | — | — | 155 | 278 | 55 | 7 | 18 | 442 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 143 | 241 | 67 | 17 | 20 | 425 |
Lymphoid leukemia | D007945 | — | C91 | 132 | 227 | 77 | 17 | 16 | 415 |
B-cell lymphoma | D016393 | — | — | 162 | 209 | 33 | 3 | 12 | 344 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 120 | 204 | 48 | 3 | 11 | 329 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 231 | 191 | 26 | — | 24 | 394 |
Myeloid leukemia acute | D015470 | — | C92.0 | 97 | 154 | 31 | — | 12 | 258 |
Myeloid leukemia | D007951 | — | C92 | 76 | 137 | 26 | — | 11 | 218 |
Melanoma | D008545 | — | — | 87 | 83 | 6 | — | 6 | 151 |
Hematologic neoplasms | D019337 | — | — | 59 | 86 | 7 | — | 8 | 136 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 68 | 72 | 10 | — | 2 | 123 |
Myeloproliferative disorders | D009196 | — | D47.1 | 34 | 82 | 4 | — | 11 | 120 |
Neuroblastoma | D009447 | EFO_0000621 | — | 49 | 46 | 22 | — | 7 | 116 |
Carcinoma | D002277 | — | C80.0 | 66 | 59 | 6 | — | 5 | 114 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 26 | 87 | 8 | — | 6 | 112 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 26 | 18 | — | — | 2 | 38 |
Mycosis fungoides | D009182 | — | C84.0 | 12 | 19 | — | — | 9 | 37 |
T-cell lymphoma cutaneous | D016410 | — | C84.A | 13 | 19 | — | — | 8 | 36 |
Mycoses | D009181 | — | B35-B49 | 10 | 18 | — | — | 5 | 30 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | 11 | 19 | — | — | 3 | 28 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 16 | 12 | — | — | 1 | 22 |
Mesothelioma | D008654 | — | C45 | 17 | 12 | — | — | 2 | 22 |
Myeloid leukemia accelerated phase | D015465 | — | — | 5 | 17 | — | — | 1 | 21 |
Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 9 | 13 | — | — | 2 | 21 |
Prolymphocytic leukemia | D015463 | — | — | 5 | 15 | — | — | 1 | 20 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Migraine disorders | D008881 | EFO_0003821 | G43 | 1 | — | — | — | 8 | 9 |
Pinealoma | D010871 | — | — | 5 | — | — | — | — | 5 |
Muscular diseases | D009135 | EFO_0002970 | G72.9 | 4 | — | — | — | — | 4 |
Adrenocortical carcinoma | D018268 | — | — | 3 | — | — | — | — | 3 |
Hepatectomy | D006498 | — | — | 1 | — | — | — | 2 | 3 |
Papillary thyroid cancer | D000077273 | — | — | 2 | — | — | — | — | 2 |
Colonic polyps | D003111 | — | K63.5 | 2 | — | — | — | — | 2 |
Barrett esophagus | D001471 | EFO_0000280 | K22.7 | 2 | — | — | — | — | 2 |
Neuroepithelial neoplasms | D018302 | — | — | 2 | — | — | — | — | 2 |
Optic nerve glioma | D020339 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | — | 6 | 6 |
Headache | D006261 | — | R51 | — | — | — | — | 4 | 4 |
Acute kidney injury | D058186 | — | N17 | — | — | — | — | 4 | 4 |
Anesthesia | D000758 | — | — | — | — | — | — | 3 | 3 |
Microvascular angina | D017566 | — | — | — | — | — | — | 3 | 3 |
Coronary circulation | D003326 | — | — | — | — | — | — | 3 | 3 |
Pathologic constriction | D003251 | — | — | — | — | — | — | 3 | 3 |
Migraine with aura | D020325 | EFO_0005295 | G43.1 | — | — | — | — | 3 | 3 |
Hemoglobin sc disease | D006450 | EFO_1001797 | D57.2 | — | — | — | — | 2 | 2 |
Dysmenorrhea | D004412 | — | N94.6 | — | — | — | — | 2 | 2 |
Drug common name | Nitroglycerin |
INN | — |
Description | Nitroglycerin is a nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain. It has a role as a vasodilator agent, a nitric oxide donor, an explosive, a prodrug, a tocolytic agent, a muscle relaxant and a xenobiotic. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-] |